Literature DB >> 28820287

Comparison of PET and CT radiomics for prediction of local tumor control in head and neck squamous cell carcinoma.

Marta Bogowicz1, Oliver Riesterer1, Luisa Sabrina Stark1, Gabriela Studer1, Jan Unkelbach1, Matthias Guckenberger1, Stephanie Tanadini-Lang1.   

Abstract

PURPOSE: An association between radiomic features extracted from CT and local tumor control in the head and neck squamous cell carcinoma (HNSCC) has been shown. This study investigated the value of pretreatment functional imaging (18F-FDG PET) radiomics for modeling of local tumor control.
MATERIAL AND METHODS: Data from HNSCC patients (n = 121) treated with definitive radiochemotherapy were used for model training. In total, 569 radiomic features were extracted from both contrast-enhanced CT and 18F-FDG PET images in the primary tumor region. CT, PET and combined PET/CT radiomic models to assess local tumor control were trained separately. Five feature selection and three classification methods were implemented. The performance of the models was quantified using concordance index (CI) in 5-fold cross validation in the training cohort. The best models, per image modality, were compared and verified in the independent validation cohort (n = 51). The difference in CI was investigated using bootstrapping. Additionally, the observed and radiomics-based estimated probabilities of local tumor control were compared between two risk groups.
RESULTS: The feature selection using principal component analysis and the classification based on the multivariabale Cox regression with backward selection of the variables resulted in the best models for all image modalities (CICT = 0.72, CIPET = 0.74, CIPET/CT = 0.77). Tumors more homogenous in CT density (decreased GLSZMsize_zone_entropy) and with a focused region of high FDG uptake (higher GLSZMSZLGE) indicated better prognosis. No significant difference in the performance of the models in the validation cohort was observed (CICT = 0.73, CIPET = 0.71, CIPET/CT = 0.73). However, the CT radiomics-based model overestimated the probability of tumor control in the poor prognostic group (predicted  = 68%, observed  = 56%).
CONCLUSIONS: Both CT and PET radiomics showed equally good discriminative power for local tumor control modeling in HNSCC. However, CT-based predictions overestimated the local control rate in the poor prognostic validation cohort, and thus, we recommend to base the local control modeling on the 18F-FDG PET.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28820287     DOI: 10.1080/0284186X.2017.1346382

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  32 in total

1.  CT-based Radiomic Signatures for Predicting Histopathologic Features in Head and Neck Squamous Cell Carcinoma.

Authors:  Pritam Mukherjee; Murilo Cintra; Chao Huang; Mu Zhou; Shankuan Zhu; A Dimitrios Colevas; Nancy Fischbein; Olivier Gevaert
Journal:  Radiol Imaging Cancer       Date:  2020-05-15

2.  Prediction of local recurrence and distant metastasis using radiomics analysis of pretreatment nasopharyngeal [18F]FDG PET/CT images.

Authors:  Lihong Peng; Xiaotong Hong; Qingyu Yuan; Lijun Lu; Quanshi Wang; Wufan Chen
Journal:  Ann Nucl Med       Date:  2021-02-04       Impact factor: 2.668

3.  Comparison of the application of B-mode and strain elastography ultrasound in the estimation of lymph node metastasis of papillary thyroid carcinoma based on a radiomics approach.

Authors:  Tongtong Liu; Xifeng Ge; Jinhua Yu; Yi Guo; Yuanyuan Wang; Wenping Wang; Ligang Cui
Journal:  Int J Comput Assist Radiol Surg       Date:  2018-06-21       Impact factor: 2.924

4.  Practical guidelines for handling head and neck computed tomography artifacts for quantitative image analysis.

Authors:  Rachel B Ger; Daniel F Craft; Dennis S Mackin; Shouhao Zhou; Rick R Layman; A Kyle Jones; Hesham Elhalawani; Clifton D Fuller; Rebecca M Howell; Heng Li; R Jason Stafford; Laurence E Court
Journal:  Comput Med Imaging Graph       Date:  2018-09-15       Impact factor: 4.790

5.  Prognostic value of the radiomics-based model in progression-free survival of hypopharyngeal cancer treated with chemoradiation.

Authors:  Xiaokai Mo; Xiangjun Wu; Di Dong; Baoliang Guo; Changhong Liang; Xiaoning Luo; Bin Zhang; Lu Zhang; Yuhao Dong; Zhouyang Lian; Jing Liu; Shufang Pei; Wenhui Huang; Fusheng Ouyang; Jie Tian; Shuixing Zhang
Journal:  Eur Radiol       Date:  2019-10-30       Impact factor: 5.315

6.  The application of radiomics in laryngeal cancer.

Authors:  Amarkumar Dhirajlal Rajgor; Shreena Patel; David McCulloch; Boguslaw Obara; Jaume Bacardit; Andrew McQueen; Eric Aboagye; Tamir Ali; James O'Hara; David Winston Hamilton
Journal:  Br J Radiol       Date:  2021-09-29       Impact factor: 3.039

Review 7.  Diagnostic Utility of Radiomics in Thyroid and Head and Neck Cancers.

Authors:  Maryam Gul; Kimberley-Jane C Bonjoc; David Gorlin; Chi Wah Wong; Amirah Salem; Vincent La; Aleksandr Filippov; Abbas Chaudhry; Muhammad H Imam; Ammar A Chaudhry
Journal:  Front Oncol       Date:  2021-07-07       Impact factor: 6.244

8.  4D radiomics: impact of 4D-CBCT image quality on radiomic analysis.

Authors:  Zeyu Zhang; Mi Huang; Zhuoran Jiang; Yushi Chang; Jordan Torok; Fang-Fang Yin; Lei Ren
Journal:  Phys Med Biol       Date:  2021-02-11       Impact factor: 3.609

9.  Targeting Treatment Resistance in Head and Neck Squamous Cell Carcinoma - Proof of Concept for CT Radiomics-Based Identification of Resistant Sub-Volumes.

Authors:  Marta Bogowicz; Matea Pavic; Oliver Riesterer; Tobias Finazzi; Helena Garcia Schüler; Edna Holz-Sapra; Leonie Rudofsky; Lucas Basler; Manon Spaniol; Andreas Ambrusch; Martin Hüllner; Matthias Guckenberger; Stephanie Tanadini-Lang
Journal:  Front Oncol       Date:  2021-05-27       Impact factor: 6.244

10.  Prognostic Value of Computed Tomography and/or 18F-Fluorodeoxyglucose Positron Emission Tomography Radiomics Features in Locally Advanced Non-small Cell Lung Cancer.

Authors:  Angel Moran; Yichuan Wang; Brandon A Dyer; Stephen S F Yip; Megan E Daly; Tokihiro Yamamoto
Journal:  Clin Lung Cancer       Date:  2021-03-27       Impact factor: 4.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.